Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05029674 · ClinicalTrials.gov registry record

Understanding Performance: Enhancing Recovery as Surgeons

A clinical trial, sponsored by Stanford University.

Completed
Registry status
66
Enrollment target

NCT05029674: Completed study, sponsored by Stanford University.

NCT05029674 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05029674 has completed, sponsored by Stanford University.

COMPLETED
Registry status
66 participants
Enrollment target

Study Summary

Reliably achieving peak performance requires balancing the strain of the prior day with sufficient recovery to be ready for the next day. Surgery has a long standing tradition long hours of hard work often at the expense of adequate sleep. Decreased sleep and recovery has physiologic consequences which can be measured using biometric data. The goal of this study is to quantify surgeon performance and biometric data to understand how modifiable behaviors can maximize recovery and performance.

Primary Outcome

A daily Recovery score from 0-100% (0-33% is poor recovery, 34-66% is medium recovery, 67-100% is good recovery) is calculated using the WHOOP algorithm which takes resting heart rate, heart rate variability, and sleep metrics into account.

Interventions

  • DEVICE Whoop

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2022-03-20
Est. Completion 2022-12-31
Stanford University

1,744 total trials

What the finished NCT05029674 record still lists

NCT05029674 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Whoop is the first listed.

NCT05029674 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05029674 about?

NCT05029674 is a clinical study titled "Understanding Performance: Enhancing Recovery as Surgeons". Reliably achieving peak performance requires balancing the strain of the prior day with sufficient recovery to be ready for the next day. Surgery has a long standing tradition long hours of hard work often at the expense of adequate sleep. Decreased sleep and recovery has physiologic consequences wh...

What is the current status of trial NCT05029674?

This trial is currently completed. The enrollment target is 66 participants. The study started on 2022-03-20. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT05029674?

The interventions under investigation include: Whoop (DEVICE).

Who is sponsoring clinical trial NCT05029674?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05029674, the US trial registry maintained by the National Library of Medicine. NCT05029674 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.